HEV study protocol : design of a cluster-randomised, blinded trial to assess the safety, immunogenicity and effectiveness of the hepatitis E vaccine HEV 239 (Hecolin) in women of childbearing age in rural Bangladesh.
Khalequ ZamanSusanne DudmanKathrine Stene-JohansenFirdausi QadriMd YunusSynne SandbuEmily S GurleyJoakim OverboCathinka Halle JulinJennifer Lynn DembinskiQuamrun NaharAnisur RahmanTaufiqur R BhuiyanMustafizur RahmanWarda HaqueJahangir KhanAsma AzizMahbuba KhanamPeter Kim StreatfieldJohn D ClemensPublished in: BMJ open (2020)
The trial is registered at clinicaltrials.gov with the registry name "Effectiveness Trial to Evaluate Protection of Pregnant Women by Hepatitis E Vaccine in Bangladesh" and the identifier NCT02759991.